Velocity’s Lafayette research site was founded in 2019 as part of MedPharmics, and acquired by Velocity in 2022. Since its inception, the site has built a reputation of success conducting trials in Pediatrics, Women’s Health, and Vaccines. Additionally, our Covington site is actively expanding to new therapeutic areas like Allergy, Asthma, and Immunology. Located just off Youngsville Highway, near Highway 90, the site is easily accessible to thousands of participants. The site shares space with the practice of one of our principal investigators, which serves as a great way to introduce clinical trials to established patients.
All trials conducted at the site are performed in accordance with ICH and FDA guidelines, and in compliance with GCP. The Lafayette team is committed to being a resource for study volunteers, to providing the highest quality of patient care with compassion and kindness and to advancing medicine through research.